Alignment Healthcare Earnings Call Shows Profitable Scale

Alignment Healthcare, Inc. ((ALHC)) has held its Q1 earnings call. Read on for the main highlights of the call.

Alignment Healthcare’s latest earnings call painted a broadly upbeat picture, with management emphasizing strong growth, expanding margins and rising efficiency despite some operational hiccups and industry uncertainty. Executives framed a one-time inpatient workflow error and higher utilization from sicker members as manageable issues, already addressed or fully reflected in their raised full-year outlook.

Surging Membership Fuels Scale Benefits

Alignment reported health plan membership of about 284,800, representing roughly 31% year-over-year growth that is building meaningful scale across its markets. Management highlighted that this expanding member base is a key driver of operating leverage, supporting both revenue expansion and the company’s path toward stronger profitability.

Revenue Growth Above 30% Underpins Momentum

Total revenue reached $1.2 billion in the first quarter, up 33% from the prior year and outpacing already-rapid membership growth. The company underscored that this top-line momentum reflects not only new members but also higher revenue per member, reinforcing confidence in the durability of its growth engine.

EBITDA Jumps as Margins Move Higher

Adjusted EBITDA climbed to $38 million, an 88% increase year-over-year, translating to a 3.1% adjusted EBITDA margin. That represented about 90 basis points of margin expansion and signaled that Alignment is converting its scale and operating improvements into tangible profit gains.

Improved Medical Cost Ratio Supports Profitability

Adjusted gross profit came in at $146 million, supported by an adjusted medical benefit ratio of 88.2%, which improved roughly 20 basis points from last year. Management pointed to this modest but meaningful MBR progress as evidence that care management programs and network initiatives are starting to show through in the numbers.

SG&A Efficiency Gains Offset Higher Investment

Adjusted SG&A rose 24% in absolute dollars to $108 million as the company continued to hire and invest in its platform. However, SG&A improved as a percentage of revenue to 8.7% from 9.4%, a roughly 60 basis point gain that management credited to automation, technology and the benefits of rising scale.

Balance Sheet Strengthens with Ample Liquidity

The company closed the quarter with $726 million in cash, cash equivalents and short-term investments, underscoring a solid liquidity position to support ongoing growth initiatives. Funded leverage improved to 2.6 times trailing 12-month EBITDA, giving Alignment more flexibility to invest while maintaining a prudent balance sheet.

Guidance Raised as Confidence Builds

Management raised full-year 2026 guidance, now projecting membership of 294,000 to 299,000 and revenue of $5.16 billion to $5.21 billion, implying about 31% growth at the midpoint. The low end of adjusted gross profit and adjusted EBITDA guidance was lifted by $5 million each, and leadership now expects around 60% of annual EBITDA to be generated in the first half of the year.

Automation and AI Drive Operational Execution

Claims auto-adjudication improved sharply, jumping from under 15% a year ago to over 60% year-to-date, a key driver of efficiency. Alignment is investing around $40 million of capital this year in software, claims automation and AI-enabled tools for contract management and risk stratification, aiming for further SG&A and medical cost improvements over time.

Clinical Performance and Part D Remain Solid

Despite some noise from a workflow issue, clinical teams kept inpatient admissions largely in line with expectations over the quarter. Part D performance was described as modestly favorable and tracking well through the first three months, providing a small tailwind to overall results in the period.

One-Time Inpatient Workflow Error Contained

A recent CMS rule change required new processes, and an internal workflow error in January led some observation cases to be paid at full acute rates, pushing admissions per 1,000 into the high 150s. Management said the problem created a multi-million dollar drag in the quarter but was corrected by the end of February and fully absorbed in first-quarter results.

Higher-Acuity Mix a Short-Term Headwind

Alignment is intentionally growing in higher-acuity populations such as chronic special needs and low-income subsidy segments, and expanding outside California. This strategy is expected to keep inpatient utilization and the medical benefit ratio higher year-over-year in 2026, but the company stressed these headwinds are already incorporated into its guidance.

Ongoing SG&A Investment Seen as Strategic

While SG&A as a share of revenue improved, the 24% year-over-year increase in absolute SG&A dollars reflects continued investment in people and technology. Management framed these costs as necessary to build a scalable infrastructure capable of supporting future growth, with the expectation that efficiency gains will continue to outpace spending.

Claims Payable and Reserve Volatility Acknowledged

Days claims payable and related reserve balances showed some volatility this quarter, partly driven by timing in the Part D line. Leadership emphasized that its reserving approach remains conservative, but investors should expect quarter-to-quarter movement in these metrics as claim timing and product mix shift.

Policy Headwinds from Modest Rate Increases

Executives flagged a challenging policy backdrop, noting that the final rate increase of about 2.48% trails underlying medical trend and could pressure 2027 bids and benefits. They also highlighted regional variation in rate updates, suggesting some markets may face more intense pressure on provider contracts and member benefits than others.

PPO Expansion Brings Execution Questions

The company’s push into PPO products and new geographies introduces uncertainty around unit economics and the depth of provider engagement needed outside its home base of California. Management candidly acknowledged that it has not yet fully solved PPO profitability at scale, making this an important area for investors to monitor as the growth strategy unfolds.

Forward-Looking Guidance Signals Strong First Half

For 2026, Alignment expects full-year membership of 294,000 to 299,000 and revenue between $5.16 billion and $5.21 billion, with adjusted gross profit of $620 million to $650 million and adjusted EBITDA of $138 million to $163 million after a $5 million raise to the low ends. Second-quarter guidance calls for revenue of $1.30 billion to $1.32 billion, adjusted gross profit of $167 million to $177 million and adjusted EBITDA of $50 million to $60 million, with management targeting about 40 basis points improvement in both MBR and SG&A and 90 to 100 basis points of EBITDA margin expansion in the first half.

Alignment Healthcare’s call delivered a clear message of strong growth, improving margins and rising operational sophistication, even as the company navigates policy uncertainty and the complexities of higher-acuity members and PPO expansion. With liquidity in place, guidance raised and investments in automation and AI accelerating, investors will now watch whether execution keeps pace with the company’s ambitious growth and profitability targets.